Literature DB >> 21371919

Hospice provision and usage amongst young people with neuromuscular disease in the United Kingdom.

L K Fraser1, J Aldridge, S Manning, S O'Leary, M Miller, R McCulloch, A M Childs.   

Abstract

AIM: To identify the nature of services for children and young people with progressive neuromuscular disorders (NMD) provided by Children's Hospices in the UK.
METHODS: A questionnaire requesting aggregate data on the number of patients with a neuromuscular condition was sent to all children's hospices in the UK, in addition, specific data was collected on services for young people with DMD presenting to a single local hospice.
RESULTS: 87% of eligible hospices responded (27/31). 756 young people with an NM condition were being cared for by the hospices. These patients accounted for a mean of 17% of the total hospice population (range 5-35%). The age at which young people were required to leave the children's hospices varied from 18 up to 35 years. 73% of 'visits' were described as 'planned stays'. Although 'end of life care' is provided, few young people with NMD died in a hospice.
CONCLUSIONS: Children and young people with NMD form a large proportion of the Children's Hospice's caseload. Many valued services provided by children's hospices are not available through NHS funding. The lack of similar adult based services is a concern as increasing numbers of young people are surviving into adulthood. Crown
Copyright © 2011. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21371919     DOI: 10.1016/j.ejpn.2011.02.003

Source DB:  PubMed          Journal:  Eur J Paediatr Neurol        ISSN: 1090-3798            Impact factor:   3.140


  1 in total

1.  The specification, acceptability and effectiveness of respite care and short breaks for young adults with complex healthcare needs: protocol for a mixed-methods systematic review.

Authors:  Gerlinde Pilkington; Katherine Knighting; Lucy Bray; Julia Downing; Barbara A Jack; Michelle Maden; Ceu Mateus; Jane Noyes; Mary R O'Brien; Brenda Roe; Anthony Tsang; Sally Spencer
Journal:  BMJ Open       Date:  2019-06-17       Impact factor: 2.692

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.